Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir Dipivoxil in Chinese Subjects With HBeAg Negative Chronic Hepatitis B
NCT00324961Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by GSK. Primary endpoint: Number of Participants Achieving HBV DNA ≤300 Copies/mL at Week 104. Started Jan 2006; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00324961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324961.